3rd Quarter - Report

FRESENIUS MEDICAL CARE NORTH AMERICA for FRESENIUS MEDICAL CARE NORTH AMERICA

Firm
Client
Income
—
Expenses
$1,020,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

H.R. 2199/S. 1173- Restore Protections for Dialysis Patients Act The Budget Reconciliation bill - the "One Big, Beautiful Bill" Act.-P.L. 119-21 The VA/MILCON Appropriations Subcommittee bill. S. 2730 - Kidney Care Access Protection Act Medicare and Medicaid coverage End Stage Renal Disease (ESRD) Prospective Payment System (PPS)

Foreign entity interest: Fresenius Medical Care AG and Co. KGaA is the sole indirect owner of Fresenius Medical Care Holdings, Inc. (dba Fresenius Medical Care North America) and has an interest in the issues lobbied.

LobbyistCovered position, as disclosed
TALEEN MEKHDJAVAKIAN —
SARAH SCHMIDT Health Policy Director, Senator John Thune Health Policy Advisor, Senator Rob Portman Legislative Assistant, Rep. Michael Burgess
COURTNEY SIMMONE VEATCH —

Contacted: Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 1173 (119th), H.R. 2199 (119th), S. 2730 (119th)

Tariff (miscellaneous tariff bills) TAR

Tariffs

Foreign entity interest: Fresenius Medical Care AG and Co. KGaA is the sole indirect owner of Fresenius Medical Care Holdings, Inc. (dba Fresenius Medical Care North America) and has interest an in the issues lobbied.

LobbyistCovered position, as disclosed
TALEEN MEKHDJAVAKIAN —
SARAH SCHMIDT New Health Policy Director, Senator John Thune Health Policy Advisor, Senator Rob Portman Legislative Assistant, Rep. Michael Burgess
COURTNEY SIMMONE VEATCH —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.